SpaceX IPO is the biggest IPO in stock market history. Join the conversation.Click here

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksEbiquity Regulatory News (EBQ)

Share Price Information for Ebiquity (EBQ)

Share Price is delayed by 15 minutes
Get Live Data
10.75    0.00 (0.00%)
Bid:
10.50
Ask:
11.00
Spread: 0.50 (4.762%)
Market Cap: £14.94m
EBQ Live PriceLast checked at - London Stock Exchange

Intraday Ebiquity Share Chart

Awards extension

21 Apr 2017 15:00

RNS Number : 0286D
Ebiquity PLC
21 April 2017
 

Ebiquity Plc

("the Company")

 

Awards extension

 

Ebiquity plc announces that the lapse date of certain share incentivisation awards (the "Awards", as defined below) made to Nick Manning (Chief Strategy Officer) and Michael Greenlees (formerly Chief Executive Officer who ceased to be a Director on 30 April 2016) has today been extended from 30 April 2017 to 30 April 2020, in order to retain flexibility for the Company. The Awards were originally due to lapse on 30 April 2015 and, as announced on 16 March 2015, were extended to 30 April 2017. The performance criteria relating to the Awards were satisfied in full prior to 30 April 2015 and the Awards are already fully exercisable.

 

In April 2010, Nick Manning was awarded share options over up to 1,800,000 ordinary shares of 25 pence each in the capital of the Company ("Ordinary Shares") and Michael Greenlees was awarded share options over up to 2,400,000 Ordinary Shares (together the "Awards"). An employee benefit trust was established and issued with 4,200,000 Ordinary Shares to satisfy exercise of the Awards.

 

Following this extension, Nick Manning's beneficial holdings in Ordinary Shares remains unchanged as he is interested in 230,000 Ordinary Shares (representing 0.3% of the Company's issued ordinary share capital) and holds options over 2,543,490 Ordinary Shares (including the Awards).

 

21 April 2017

 

Notification and public disclosure of transactions by persons discharging managerial responsibilities and persons closely associated with them

 

1

Details of the person discharging managerial responsibilities/person closely associated

a)

Name:

 

Nicholas Vincent Manning

Reason for the notification

 

a)

Position/status:

 

Chief Strategy Officer

b)

Initial notification/Amendment:

 

Initial notification

Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor

 

a)

Name:

 

Ebiquity plc

b)

LEI:

 

2138004YRTDJ7FJSWF20

Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted

 

a)

Description of the financial instrument, type of instrument:

Identification code:

 

Options over ordinary shares of £0.25 each

GB0004126057

b)

Nature of the transaction:

Extension of the lapse date of the options from 30 April 2017 to 30 April 2020.

c)

Price(s) and volume(s):

 

 

Price(s)

Volume(s)

N/A

1,800,000

d)

Aggregated information:

· Aggregated volume:

· Price:

· average price of the aggregated transactions.

· 1,800,000

· N/A

e)

Date of the transaction:

21 April 2017

 

f)

Place of the transaction:

Outside trading venue

 

 

 

Enquiries:

Ebiquity plc

Michael Karg (CEO)

Andrew Noble (CFO)

 

Instinctif Partners

Matthew Smallwood

Guy Scarborough

 

020 7650 9600

 

 

 

020 7457 2020

Numis Securities Limited

Nick Westlake Oliver Hardy (NOMAD)

Toby Adcock (Corporate Broker)

020 7260 1000

 

 

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
MSCPGUPCCUPMGWG
Date   Source Headline
9th Sep 20167:00 amRNSAppointment of CFO and Director
6th Sep 20167:00 amRNSLaunch of new Advertising Intelligence platform
27th Jul 20167:00 amRNSTrading Statement
19th Jul 20167:30 amRNSGuidelines for achieving media transparency
19th Jul 20167:00 amRNSRe: Directorate
12th Jul 201611:45 amRNSTR-1: Notification of Major Interest in Shares
22nd Jun 201611:05 amRNSTR1
9th Jun 20161:50 pmRNSCapital Reduction effective
8th Jun 201611:40 amRNSCourt confirmation of Capital Reduction
3rd Jun 20163:50 pmRNSDirector dealing
20th May 20167:00 amRNSHolding(s) in Company
19th May 20162:25 pmRNSHolding(s) in Company
11th May 201611:20 amRNSAGM resolutions passed
11th May 20168:50 amRNSExercise of Share Options
29th Apr 20165:30 pmRNSRe Directorate
25th Apr 201610:45 amRNSHolding(s) in Company
15th Apr 20163:40 pmRNSAnnual Report
30th Mar 20167:00 amRNSFinal Results
27th Jan 20167:00 amRNSAppointment of Director and Director Dealing
27th Jan 20167:00 amRNSInterim Results
8th Jan 201611:27 amRNSHolding(s) in Company
26th Nov 20157:00 amRNSTrading Statement
25th Nov 20152:41 pmRNSDirector Dealing
9th Nov 201512:15 pmRNSCORRECTION - Holding(s) in Company
9th Nov 201510:21 amRNSHolding(s) in Company
6th Nov 201511:53 amRNSHolding(s) in Company
15th Oct 20157:10 amRNSExercise of Share Options
15th Oct 20157:00 amRNSAppointment of director
12th Oct 20152:21 pmRNSDirector Dealing
2nd Oct 20157:00 amRNSDirector Dealings
1st Oct 20157:00 amRNSBoard changes
22nd Sep 20154:48 pmRNSExercise of Share Options
17th Sep 20157:00 amRNSFinal dividend for the year ended 30 April 2015
15th Sep 20153:33 pmRNSResult of AGM
17th Aug 20157:00 amRNSAnnual Financial Report
28th Jul 20157:10 amRNSChange in financial year end
28th Jul 20157:00 amRNSFinal Results
6th Jul 20155:56 pmRNSHolding(s) in Company
25th Jun 201512:15 pmRNSHolding(s) in Company
24th Jun 20154:22 pmRNSHolding(s) in Company
24th Jun 20157:00 amRNSChange to final results announcement date
9th Jun 20154:13 pmRNSHolding(s) in Company
8th Jun 20152:43 pmRNSHolding(s) in Company
8th Jun 201511:10 amRNSHolding(s) in Company
1st Jun 201510:37 amRNSExercise of Share Options
27th May 20157:00 amRNSExercise of Share Options
27th May 20157:00 amRNSPre-close Trading Statement
22nd May 20155:15 pmRNSHolding(s) in Company
19th May 20157:00 amRNSExercise of Share Options
16th Mar 20154:30 pmRNSDirector/PDMR Shareholding

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.